Haleon (HLN) Cash from Discontinued Operations (2021 - 2023)
Haleon (HLN) posted Cash from Discontinued Operations of 929622762.15 for Q4 2023, up 16.55% on a QoQ basis from 797591258.37 in Q4 2022, and up 16.55% year-over-year from 797591258.37 in Q4 2022.
Haleon (HLN) Cash from Discontinued Operations (2021 - 2023) Analysis & Trends
Haleon's Cash from Discontinued Operations history runs 3 years deep, the most recent figure standing at 929622762.15 for Q4 2023.
- Quarterly Cash from Discontinued Operations rose 16.55% year-over-year to 929622762.15 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 2879929120.14 (changed N/A YoY) and the FY2024 annual result came in at 2941311634.91, up 12.61% from the prior year.
- Cash from Discontinued Operations was 929622762.15 for Q4 2023 at Haleon, up from 797591258.37 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 929622762.15 in Q4 2023 and bottomed at 315434482.08 in Q4 2021.
- A 3-year average of 719982280.03 and a median of 817435937.95 in 2022 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2022 — Cash from Discontinued Operations surged 152.85% — and 2023, when it gained 16.55%.
- Haleon's Cash from Discontinued Operations stood at 315434482.08 in 2021, then jumped by 152.85% to 797591258.37 in 2022, then climbed by 16.55% to 929622762.15 in 2023.
- Business Quant data shows HLN's Cash from Discontinued Operations at 929622762.15 in Q4 2023, 797591258.37 in Q4 2022, and 837280617.53 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 929.62 Mn |
| Dec 31, 2023 | 929.62 Mn |
| Dec 31, 2022 | 797.59 Mn |
| Dec 31, 2022 | 797.59 Mn |
| Sep 20, 2022 | 837.28 Mn |
| Sep 20, 2022 | 837.28 Mn |
| Dec 31, 2021 | 315.43 Mn |
| Dec 31, 2021 | 315.43 Mn |